Industry Research Reports

Home > Reports > Medical Devices & Consumables > Automatic Insulin Dosing Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Automatic Insulin Dosing Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-11

Pages: 121 Pages

Report ld: 2638898

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Automatic Insulin Dosing Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Automatic Insulin Dosing Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automatic Insulin Dosing Device by region & country, by Type, and by Application.

The Automatic Insulin Dosing Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Insulin Dosing Device.

Market Segmentation

Report Metric
Details
Report Title
Automatic Insulin Dosing Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Automatic Insulin Dosing Device Companies Covered
Medtronic, Dexcom, Abbott, Insulet, Tandem Diabetes Care, Bigfoot Biomedical, Beta Bionics, Admetsys, Defymed, Micro Tech Medical
Global Automatic Insulin Dosing Device Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Automatic Insulin Dosing Device Market, Segment by Type
Threshold Suspended Device Systems

Hybrid Closed-loop APDS

Other
Global Automatic Insulin Dosing Device Market, Segment by Application
Hospital

Clinic

Home Care

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Automatic Insulin Dosing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Automatic Insulin Dosing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Automatic Insulin Dosing Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Automatic Insulin Dosing Device Product Introduction
    1.2 Global Automatic Insulin Dosing Device Market Size Forecast
        1.2.1 Global Automatic Insulin Dosing Device Sales Value (2019-2030)
        1.2.2 Global Automatic Insulin Dosing Device Sales Volume (2019-2030)
        1.2.3 Global Automatic Insulin Dosing Device Sales Price (2019-2030)
    1.3 Automatic Insulin Dosing Device Market Trends & Drivers
        1.3.1 Automatic Insulin Dosing Device Industry Trends
        1.3.2 Automatic Insulin Dosing Device Market Drivers & Opportunity
        1.3.3 Automatic Insulin Dosing Device Market Challenges
        1.3.4 Automatic Insulin Dosing Device Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Automatic Insulin Dosing Device Players Revenue Ranking (2023)
    2.2 Global Automatic Insulin Dosing Device Revenue by Company (2019-2024)
    2.3 Global Automatic Insulin Dosing Device Players Sales Volume Ranking (2023)
    2.4 Global Automatic Insulin Dosing Device Sales Volume by Company Players (2019-2024)
    2.5 Global Automatic Insulin Dosing Device Average Price by Company (2019-2024)
    2.6 Key Manufacturers Automatic Insulin Dosing Device Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Automatic Insulin Dosing Device Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Automatic Insulin Dosing Device
    2.9 Automatic Insulin Dosing Device Market Competitive Analysis
        2.9.1 Automatic Insulin Dosing Device Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Automatic Insulin Dosing Device Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automatic Insulin Dosing Device as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Threshold Suspended Device Systems
        3.1.2 Hybrid Closed-loop APDS
        3.1.3 Other
    3.2 Global Automatic Insulin Dosing Device Sales Value by Type
        3.2.1 Global Automatic Insulin Dosing Device Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Automatic Insulin Dosing Device Sales Value, by Type (2019-2030)
        3.2.3 Global Automatic Insulin Dosing Device Sales Value, by Type (%) (2019-2030)
    3.3 Global Automatic Insulin Dosing Device Sales Volume by Type
        3.3.1 Global Automatic Insulin Dosing Device Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Automatic Insulin Dosing Device Sales Volume, by Type (2019-2030)
        3.3.3 Global Automatic Insulin Dosing Device Sales Volume, by Type (%) (2019-2030)
    3.4 Global Automatic Insulin Dosing Device Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Home Care
        4.1.4 Others
    4.2 Global Automatic Insulin Dosing Device Sales Value by Application
        4.2.1 Global Automatic Insulin Dosing Device Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Automatic Insulin Dosing Device Sales Value, by Application (2019-2030)
        4.2.3 Global Automatic Insulin Dosing Device Sales Value, by Application (%) (2019-2030)
    4.3 Global Automatic Insulin Dosing Device Sales Volume by Application
        4.3.1 Global Automatic Insulin Dosing Device Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Automatic Insulin Dosing Device Sales Volume, by Application (2019-2030)
        4.3.3 Global Automatic Insulin Dosing Device Sales Volume, by Application (%) (2019-2030)
    4.4 Global Automatic Insulin Dosing Device Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Automatic Insulin Dosing Device Sales Value by Region
        5.1.1 Global Automatic Insulin Dosing Device Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Automatic Insulin Dosing Device Sales Value by Region (2019-2024)
        5.1.3 Global Automatic Insulin Dosing Device Sales Value by Region (2025-2030)
        5.1.4 Global Automatic Insulin Dosing Device Sales Value by Region (%), (2019-2030)
    5.2 Global Automatic Insulin Dosing Device Sales Volume by Region
        5.2.1 Global Automatic Insulin Dosing Device Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Automatic Insulin Dosing Device Sales Volume by Region (2019-2024)
        5.2.3 Global Automatic Insulin Dosing Device Sales Volume by Region (2025-2030)
        5.2.4 Global Automatic Insulin Dosing Device Sales Volume by Region (%), (2019-2030)
    5.3 Global Automatic Insulin Dosing Device Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Automatic Insulin Dosing Device Sales Value, 2019-2030
        5.4.2 North America Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Automatic Insulin Dosing Device Sales Value, 2019-2030
        5.5.2 Europe Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Automatic Insulin Dosing Device Sales Value, 2019-2030
        5.6.2 Asia Pacific Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Automatic Insulin Dosing Device Sales Value, 2019-2030
        5.7.2 South America Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Automatic Insulin Dosing Device Sales Value, 2019-2030
        5.8.2 Middle East & Africa Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Automatic Insulin Dosing Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Automatic Insulin Dosing Device Sales Value
        6.2.1 Key Countries/Regions Automatic Insulin Dosing Device Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Automatic Insulin Dosing Device Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Automatic Insulin Dosing Device Sales Value, 2019-2030
        6.3.2 United States Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Automatic Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Automatic Insulin Dosing Device Sales Value, 2019-2030
        6.4.2 Europe Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Automatic Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Automatic Insulin Dosing Device Sales Value, 2019-2030
        6.5.2 China Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Automatic Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Automatic Insulin Dosing Device Sales Value, 2019-2030
        6.6.2 Japan Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Automatic Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Automatic Insulin Dosing Device Sales Value, 2019-2030
        6.7.2 South Korea Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Automatic Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Automatic Insulin Dosing Device Sales Value, 2019-2030
        6.8.2 Southeast Asia Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Automatic Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Automatic Insulin Dosing Device Sales Value, 2019-2030
        6.9.2 India Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Automatic Insulin Dosing Device Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Medtronic
        7.1.1 Medtronic Company Information
        7.1.2 Medtronic Introduction and Business Overview
        7.1.3 Medtronic Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Medtronic Automatic Insulin Dosing Device Product Offerings
        7.1.5 Medtronic Recent Development
    7.2 Dexcom
        7.2.1 Dexcom Company Information
        7.2.2 Dexcom Introduction and Business Overview
        7.2.3 Dexcom Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Dexcom Automatic Insulin Dosing Device Product Offerings
        7.2.5 Dexcom Recent Development
    7.3 Abbott
        7.3.1 Abbott Company Information
        7.3.2 Abbott Introduction and Business Overview
        7.3.3 Abbott Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Abbott Automatic Insulin Dosing Device Product Offerings
        7.3.5 Abbott Recent Development
    7.4 Insulet
        7.4.1 Insulet Company Information
        7.4.2 Insulet Introduction and Business Overview
        7.4.3 Insulet Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Insulet Automatic Insulin Dosing Device Product Offerings
        7.4.5 Insulet Recent Development
    7.5 Tandem Diabetes Care
        7.5.1 Tandem Diabetes Care Company Information
        7.5.2 Tandem Diabetes Care Introduction and Business Overview
        7.5.3 Tandem Diabetes Care Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Tandem Diabetes Care Automatic Insulin Dosing Device Product Offerings
        7.5.5 Tandem Diabetes Care Recent Development
    7.6 Bigfoot Biomedical
        7.6.1 Bigfoot Biomedical Company Information
        7.6.2 Bigfoot Biomedical Introduction and Business Overview
        7.6.3 Bigfoot Biomedical Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Bigfoot Biomedical Automatic Insulin Dosing Device Product Offerings
        7.6.5 Bigfoot Biomedical Recent Development
    7.7 Beta Bionics
        7.7.1 Beta Bionics Company Information
        7.7.2 Beta Bionics Introduction and Business Overview
        7.7.3 Beta Bionics Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Beta Bionics Automatic Insulin Dosing Device Product Offerings
        7.7.5 Beta Bionics Recent Development
    7.8 Admetsys
        7.8.1 Admetsys Company Information
        7.8.2 Admetsys Introduction and Business Overview
        7.8.3 Admetsys Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Admetsys Automatic Insulin Dosing Device Product Offerings
        7.8.5 Admetsys Recent Development
    7.9 Defymed
        7.9.1 Defymed Company Information
        7.9.2 Defymed Introduction and Business Overview
        7.9.3 Defymed Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Defymed Automatic Insulin Dosing Device Product Offerings
        7.9.5 Defymed Recent Development
    7.10 Micro Tech Medical
        7.10.1 Micro Tech Medical Company Information
        7.10.2 Micro Tech Medical Introduction and Business Overview
        7.10.3 Micro Tech Medical Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Micro Tech Medical Automatic Insulin Dosing Device Product Offerings
        7.10.5 Micro Tech Medical Recent Development

 8 Industry Chain Analysis
    8.1 Automatic Insulin Dosing Device Industrial Chain
    8.2 Automatic Insulin Dosing Device Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Automatic Insulin Dosing Device Sales Model
        8.5.2 Sales Channel
        8.5.3 Automatic Insulin Dosing Device Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Automatic Insulin Dosing Device Market Trends
    Table 2. Automatic Insulin Dosing Device Market Drivers & Opportunity
    Table 3. Automatic Insulin Dosing Device Market Challenges
    Table 4. Automatic Insulin Dosing Device Market Restraints
    Table 5. Global Automatic Insulin Dosing Device Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Automatic Insulin Dosing Device Revenue Market Share by Company (2019-2024)
    Table 7. Global Automatic Insulin Dosing Device Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Automatic Insulin Dosing Device Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Automatic Insulin Dosing Device Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Automatic Insulin Dosing Device Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Automatic Insulin Dosing Device Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Automatic Insulin Dosing Device
    Table 13. Global Automatic Insulin Dosing Device Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automatic Insulin Dosing Device as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Automatic Insulin Dosing Device Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Automatic Insulin Dosing Device Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Automatic Insulin Dosing Device Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Automatic Insulin Dosing Device Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Automatic Insulin Dosing Device Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Automatic Insulin Dosing Device Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Automatic Insulin Dosing Device Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Automatic Insulin Dosing Device Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Automatic Insulin Dosing Device Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Automatic Insulin Dosing Device Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Automatic Insulin Dosing Device Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Automatic Insulin Dosing Device Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Automatic Insulin Dosing Device Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Automatic Insulin Dosing Device Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Automatic Insulin Dosing Device Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Automatic Insulin Dosing Device Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Automatic Insulin Dosing Device Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Automatic Insulin Dosing Device Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Automatic Insulin Dosing Device Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Automatic Insulin Dosing Device Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Automatic Insulin Dosing Device Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Automatic Insulin Dosing Device Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Automatic Insulin Dosing Device Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Automatic Insulin Dosing Device Sales Value by Region (2019-2024) & (%)
    Table 44. Global Automatic Insulin Dosing Device Sales Value by Region (2025-2030) & (%)
    Table 45. Global Automatic Insulin Dosing Device Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Automatic Insulin Dosing Device Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Automatic Insulin Dosing Device Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Automatic Insulin Dosing Device Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Automatic Insulin Dosing Device Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Automatic Insulin Dosing Device Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Automatic Insulin Dosing Device Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Automatic Insulin Dosing Device Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Automatic Insulin Dosing Device Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Automatic Insulin Dosing Device Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Automatic Insulin Dosing Device Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Automatic Insulin Dosing Device Sales Volume, (2025-2030) & (K Units)
    Table 57. Medtronic Company Information
    Table 58. Medtronic Introduction and Business Overview
    Table 59. Medtronic Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Medtronic Automatic Insulin Dosing Device Product Offerings
    Table 61. Medtronic Recent Development
    Table 62. Dexcom Company Information
    Table 63. Dexcom Introduction and Business Overview
    Table 64. Dexcom Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Dexcom Automatic Insulin Dosing Device Product Offerings
    Table 66. Dexcom Recent Development
    Table 67. Abbott Company Information
    Table 68. Abbott Introduction and Business Overview
    Table 69. Abbott Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Abbott Automatic Insulin Dosing Device Product Offerings
    Table 71. Abbott Recent Development
    Table 72. Insulet Company Information
    Table 73. Insulet Introduction and Business Overview
    Table 74. Insulet Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Insulet Automatic Insulin Dosing Device Product Offerings
    Table 76. Insulet Recent Development
    Table 77. Tandem Diabetes Care Company Information
    Table 78. Tandem Diabetes Care Introduction and Business Overview
    Table 79. Tandem Diabetes Care Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Tandem Diabetes Care Automatic Insulin Dosing Device Product Offerings
    Table 81. Tandem Diabetes Care Recent Development
    Table 82. Bigfoot Biomedical Company Information
    Table 83. Bigfoot Biomedical Introduction and Business Overview
    Table 84. Bigfoot Biomedical Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Bigfoot Biomedical Automatic Insulin Dosing Device Product Offerings
    Table 86. Bigfoot Biomedical Recent Development
    Table 87. Beta Bionics Company Information
    Table 88. Beta Bionics Introduction and Business Overview
    Table 89. Beta Bionics Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Beta Bionics Automatic Insulin Dosing Device Product Offerings
    Table 91. Beta Bionics Recent Development
    Table 92. Admetsys Company Information
    Table 93. Admetsys Introduction and Business Overview
    Table 94. Admetsys Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Admetsys Automatic Insulin Dosing Device Product Offerings
    Table 96. Admetsys Recent Development
    Table 97. Defymed Company Information
    Table 98. Defymed Introduction and Business Overview
    Table 99. Defymed Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Defymed Automatic Insulin Dosing Device Product Offerings
    Table 101. Defymed Recent Development
    Table 102. Micro Tech Medical Company Information
    Table 103. Micro Tech Medical Introduction and Business Overview
    Table 104. Micro Tech Medical Automatic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Micro Tech Medical Automatic Insulin Dosing Device Product Offerings
    Table 106. Micro Tech Medical Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Automatic Insulin Dosing Device Downstream Customers
    Table 110. Automatic Insulin Dosing Device Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Automatic Insulin Dosing Device Product Picture
    Figure 2. Global Automatic Insulin Dosing Device Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Automatic Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Automatic Insulin Dosing Device Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Automatic Insulin Dosing Device Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Automatic Insulin Dosing Device Report Years Considered
    Figure 7. Global Automatic Insulin Dosing Device Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Automatic Insulin Dosing Device Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Automatic Insulin Dosing Device Revenue in 2023
    Figure 10. Automatic Insulin Dosing Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Threshold Suspended Device Systems Picture
    Figure 12. Hybrid Closed-loop APDS Picture
    Figure 13. Other Picture
    Figure 14. Global Automatic Insulin Dosing Device Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Automatic Insulin Dosing Device Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Automatic Insulin Dosing Device Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Automatic Insulin Dosing Device Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Automatic Insulin Dosing Device Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Clinic
    Figure 21. Product Picture of Home Care
    Figure 22. Product Picture of Others
    Figure 23. Global Automatic Insulin Dosing Device Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Automatic Insulin Dosing Device Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Automatic Insulin Dosing Device Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Automatic Insulin Dosing Device Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Automatic Insulin Dosing Device Price by Application (2019-2030) & (US$/Unit)
    Figure 28. North America Automatic Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Automatic Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Automatic Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Automatic Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Automatic Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Automatic Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Automatic Insulin Dosing Device Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Automatic Insulin Dosing Device Sales Volume (%), (2019-2030)
    Figure 40. United States Automatic Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Automatic Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Automatic Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Automatic Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Automatic Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Automatic Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Automatic Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Automatic Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Automatic Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Automatic Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Automatic Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Automatic Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Automatic Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Automatic Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Automatic Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 61. Automatic Insulin Dosing Device Industrial Chain
    Figure 62. Automatic Insulin Dosing Device Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Description

The global market for Automatic Insulin Dosing Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Automatic Insulin Dosing Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automatic Insulin Dosing Device by region & country, by Type, and by Application.

The Automatic Insulin Dosing Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Insulin Dosing Device.

Market Segmentation